Rosalind Advisors, Inc.

Rosalind Advisors, Inc. reported 35 holdings worth US$269M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 14, 2026

Rosalind Advisors, Inc. reported 35 holdings worth US$269M as of Jun 30, 2026. Largest: Delcath Systems, Inc., Fennec Pharmaceuticals Inc. and Xeris Biopharma Holdings, Inc. Filed Aug 14, 2026 (Form 13F).

Holdings
35
Value as reported
US$269M

The filing in full

CompanySharesValue as reported% of portfolio
Delcath Systems, Inc.3.3MUS$41.6M15.4%
Fennec Pharmaceuticals Inc.3.19MUS$34.3M12.7%
Xeris Biopharma Holdings, Inc.2.91MUS$23M8.6%
Savara, Inc.3.18MUS$19.6M7.3%
Verastem, Inc.3.99MUS$15.2M5.7%
X4 Pharmaceuticals, Inc.3.21MUS$15M5.6%
Eyepoint, Inc.988KUS$14.1M5.2%
Cybin, Inc.1.96MUS$12.9M4.8%
Vor Biopharma Inc.649KUS$11.9M4.4%
Vaxcyte, Inc.200KUS$11.6M4.3%
Celldex Therapeutics, Inc.200KUS$7.44M2.8%
Biocryst Pharmaceuticals, Inc.722KUS$7.22M2.7%
Profound Medical Corp828KUS$5.51M2.0%
Talphera, Inc.5.17MUS$5.32M2.0%
Atea Pharmaceuticals, Inc.1.07MUS$4.98M1.8%
Myomo Inc.3.64MUS$3.78M1.4%
Ovid Therapeutics Inc.1.11MUS$2.98M1.1%
Neuraxis, Inc.508KUS$2.97M1.1%
Abivax Sa20,869US$2.78M1.0%
Inspiremd Inc.3.91MUS$2.73M1.0%
Biofrontera Inc.1.28MUS$1.21M0.45%
Kura Oncology, Inc.100KUS$1.1M0.41%
Spruce Biosciences, Inc.20,000US$1.08M0.40%
Aquestive Therapeutics, Inc.250KUS$1.04M0.39%
Onkure Therapeutics, Inc.150KUS$684K0.25%
Pepgen Inc.350KUS$630K0.23%
Annexon, Inc.0US$00.00%
Avalo Therapeutics, Inc.0US$00.00%
Cg Oncology, Inc.0US$00.00%
Definium Therapeutics, Inc.0US$00.00%
Lipocine Inc.0US$00.00%
Viridian Therapeutics, Inc.0US$00.00%

Source

View original at SEC

Related